• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,490.53 -1,173.47
( -1.51%)
Global Indices
Nasdaq
49,330.80 -180.24
(-0.36%)
Dow Jones
7,129.46 -29.44
(-0.41%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,468.22 -8.24
(-0.08%)
Forex
USD-INR
93.75 0.31
(0.34%)
EUR-INR
109.98 0.10
(0.09%)
GBP-INR
126.66 0.42
(0.33%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Pacific Industries Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
523483
INE883C01025
250.8630933
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PACIFICIND
30.27
95.77
EPS(TTM)
Face Value()
Div & Yield %
4.59
10
0
 

Ajanta Pharma's Paithan unit concludes USFDA inspection
Apr 22,2026
Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.